text_1: Increased mobility of retrotransposons is assosciated with mutation and higher tumorigenesis rates.
text_2: We found that 68.4% of CpG sites and <0.2% of non-CpG sites were methylated, demonstrating that non-CpG cytosine methylation is minor in human PBMC.